CEFACLOR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins
|
|
- Esther Waters
- 6 years ago
- Views:
Transcription
1 Report generated from BNF - Local Information provided by FormularyComplete ( Accessed Title Formulary Status Section Amikacin Non Formulary 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->AMIKACIN Amikin Non Formulary 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->AMIKACIN AMPICILLIN Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins Ampicillin Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->ampicillin Artemether with lumefantrine Non Formulary 5.4 Antiprotozoal drugs->5.4.1 Antimalarials CAPREOMYCIN Non Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Capreomycin Non Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->capreomycin CEFACLOR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Cefaclor Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFACLOR CEFADROXIL Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Cefadroxil Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFADROXIL CEFRADINE Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Cefradine Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFRADINE CEFTAROLINE FOSAMIL Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins CLOFAZIMINE Non Formulary 5.1 Antibacterial drugs-> Antileprotic drugs Clofazimine Non Formulary 5.1 Antibacterial drugs-> Antileprotic drugs->clofazimine Co-amoxiclav Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->co-amoxiclav->other oral preparations Crixivan Non Formulary 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->indinavir CYCLOSERINE Non Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Cycloserine Non Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->cycloserine DEMECLOCYCLINE HYDROCHLORIDE Non Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines
2 Distaclor MR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFACLOR->Modified release Distaclor Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFACLOR Efracea Non Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines->DOXYCYCLINE->Modified-release Erymax Non Formulary 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN Erythromycin Lactobionate Non Formulary 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN Erythroped A Non Formulary 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN Imunovir Non Formulary 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection->inosine PRANOBEX INDINAVIR Non Formulary 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors Inhalation Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Other beta-lactam antibiotics->aztreonam INOSINE PRANOBEX Non Formulary 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection Isotonic Gentamicin Injection Non Formulary 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->GENTAMICIN Macrobid Non Formulary 5.1 Antibacterial drugs-> Urinary-tract infections->nitrofurantoin->modified release MICAFUNGIN Non Formulary 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals Minocycline m/r preparations Non Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines->MINOCYCLINE->Modified release Modified-release Non Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines->DOXYCYCLINE Modified release Non Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines->MINOCYCLINE Modified release Non Formulary 5.1 Antibacterial drugs-> Urinary-tract infections->nitrofurantoin Mycobutin Non Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->rifabutin NALIDIXIC ACID Non Formulary 5.1 Antibacterial drugs-> Quinolones Nalidixic Acid Non Formulary 5.1 Antibacterial drugs-> Quinolones->NALIDIXIC ACID Negaban Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Penicillinase-resistant penicillins->temocillin NORFLOXACIN Non Formulary 5.1 Antibacterial drugs-> Quinolones Norfloxacin Non Formulary 5.1 Antibacterial drugs-> Quinolones->NORFLOXACIN Other oral preparations Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->co-amoxiclav
3 Penbritin Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->ampicillin Primaxin Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Carbapenems->IMIPENEM WITH CILASTATIN PYRIMETHAMINE WITH SULFADOXINE Non Formulary 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Pyrimethamine RIFABUTIN Non Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs RILPIVIRINE Non Formulary 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors Sebivo Non Formulary 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis B->TELBIVUDINE SODIUM STIBOGLUCONATE Non Formulary 5.4 Antiprotozoal drugs->5.4.5 Leishmaniacides Streptomycin Sulfate Non Formulary 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->streptomycin SULFADIAZINE Non Formulary 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim Sulfadiazine Non Formulary 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->sulfadiazine TELBIVUDINE Non Formulary 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis B TEMOCILLIN Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Penicillinase-resistant penicillins Tetracycline Non Formulary 5.1 Antibacterial drugs->5.1.3 Tetracyclines->TETRACYCLINE TICARCILLIN WITH CLAVULANIC ACID Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Antipseudomonal penicillins Timentin Non Formulary 5.1 Antibacterial drugs->5.1.1 Penicillins-> Antipseudomonal penicillins->ticarcillin WITH CLAVULANIC ACID TIPRANAVIR Non Formulary 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors Xifaxanta Non Formulary 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->rifaximin->rifaximin Zinnat Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFUROXIME ABACAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors ACICLOVIR 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection Aciclovir 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection->aciclovir ADEFOVIR DIPIVOXIL 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis B AMANTADINE HYDROCHLORIDE 5.3 Antiviral drugs->5.3.4 Influenza AMOXICILLIN 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins
4 Amoxicillin 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->amoxicillin Amoxil 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->amoxicillin AMPHOTERICIN 5.2 Antifungal drugs->5.2.3 Polyene antifungals ANIDULAFUNGIN 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals Aptivus 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->tipranavir ATAZANAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors ATOVAQUONE 5.4 Antiprotozoal drugs->5.4.8 Drugs for pneumocystis pneumonia Atripla 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->tenofovir DISOPROXIL->With efavirenz and emtricitabine Augmentin 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->co-amoxiclav Avloclor 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Chloroquine->CHLOROQUINE Baraclude 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis B->ENTECAVIR Benzylpenicillin and phenoxymethylpenicillin 5.1 Antibacterial drugs->5.1.1 Penicillins BENZYLPENICILLIN SODIUM 5.1 Antibacterial drugs->5.1.1 Penicillins-> Benzylpenicillin and phenoxymethylpenicillin BOCEPREVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C CASPOFUNGIN 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals Celsentri 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals->maraviroc Chloramphenicol 5.1 Antibacterial drugs->5.1.7 Some other antibacterials CHLORAMPHENICOL 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->chloramphenicol Chloroquine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials CHLOROQUINE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Chloroquine Cidomycin 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->GENTAMICIN CLARITHROMYCIN 5.1 Antibacterial drugs->5.1.5 Macrolides Clarithromycin 5.1 Antibacterial drugs->5.1.5 Macrolides->CLARITHROMYCIN CLINDAMYCIN 5.1 Antibacterial drugs->5.1.6 Clindamycin Clindamycin 5.1 Antibacterial drugs->5.1.6 Clindamycin->CLINDAMYCIN
5 CO-AMOXICLAV 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins Co-amoxiclav 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->co-amoxiclav CO-FLUAMPICIL 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins Co-fluampicil 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->co-fluampicil COLISTIMETHATE SODIUM 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->polymyxins Combined preparations 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->rifampicin Combivir 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->zidovudine->with lamivudine Crystapen 5.1 Antibacterial drugs->5.1.1 Penicillins-> Benzylpenicillin and phenoxymethylpenicillin->benzylpenicillin SODIUM Cymevene 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Cytomegalovirus infection->ganciclovir Dalacin C 5.1 Antibacterial drugs->5.1.6 Clindamycin->CLINDAMYCIN DARUNAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors DIDANOSINE 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors Diflucan 5.2 Antifungal drugs->5.2.1 Triazole antifungals->fluconazole Diloxanide 5.4 Antiprotozoal drugs->5.4.2 Amoebicides->DILOXANIDE FUROATE DILOXANIDE FUROATE 5.4 Antiprotozoal drugs->5.4.2 Amoebicides DOXYCYCLINE 5.1 Antibacterial drugs->5.1.3 Tetracyclines Doxycycline 5.1 Antibacterial drugs->5.1.3 Tetracyclines->DOXYCYCLINE DOXYCYCLINE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Tetracyclines EFAVIRENZ 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors EMTRICITABINE 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors Emtriva 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->emtricitabine ENFUVIRTIDE 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals ENTECAVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis B Epivir 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->lamivudine Erythrocin 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN ERYTHROMYCIN 5.1 Antibacterial drugs->5.1.5 Macrolides Erythromycin 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN
6 Erythromycin Ethyl Succinate 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN Erythroped 5.1 Antibacterial drugs->5.1.5 Macrolides->ERYTHROMYCIN Ethambutol 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->ethambutol HYDROCHLORIDE ETHAMBUTOL HYDROCHLORIDE 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs ETRAVIRINE 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors FAMCICLOVIR 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection Famciclovir 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection->famciclovir Famvir 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection->famciclovir Flagyl 5.1 Antibacterial drugs-> Metronidazole and tinidazole->metronidazole FLUCLOXACILLIN 5.1 Antibacterial drugs->5.1.1 Penicillins-> Penicillinase-resistant penicillins Flucloxacillin 5.1 Antibacterial drugs->5.1.1 Penicillins-> Penicillinase-resistant penicillins->flucloxacillin FLUCONAZOLE 5.2 Antifungal drugs->5.2.1 Triazole antifungals Fluconazole 5.2 Antifungal drugs->5.2.1 Triazole antifungals->fluconazole FLUCYTOSINE 5.2 Antifungal drugs->5.2.5 Other antifungals FOSAMPRENAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors FOSCARNET SODIUM 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Cytomegalovirus infection Foscavir 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Cytomegalovirus infection->foscarnet SODIUM Fungizone 5.2 Antifungal drugs->5.2.3 Polyene antifungals->amphotericin Fuzeon 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals->enfuvirtide GANCICLOVIR 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Cytomegalovirus infection GENTAMICIN 5.1 Antibacterial drugs->5.1.4 Aminoglycosides Gentamicin 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->GENTAMICIN Genticin 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->GENTAMICIN GRISEOFULVIN 5.2 Antifungal drugs->5.2.5 Other antifungals Hepsera 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis B->ADEFOVIR DIPIVOXIL
7 Intelence 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors->etravirine Invirase 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->saquinavir Isentress 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals->raltegravir ISONIAZID 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Isoniazid 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->isoniazid ITRACONAZOLE 5.2 Antifungal drugs->5.2.1 Triazole antifungals Itraconazole 5.2 Antifungal drugs->5.2.1 Triazole antifungals->itraconazole Kaletra 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->lopinavir WITH RITONAVIR Kivexa 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->abacavir->with lamivudine Klaricid XL 5.1 Antibacterial drugs->5.1.5 Macrolides->CLARITHROMYCIN->Modified release Klaricid 5.1 Antibacterial drugs->5.1.5 Macrolides->CLARITHROMYCIN LAMIVUDINE 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors Lipid formulations 5.2 Antifungal drugs->5.2.3 Polyene antifungals->amphotericin LOPINAVIR WITH RITONAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors Magnapen 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->co-fluampicil MARAVIROC 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals MEBENDAZOLE 5.5 Anthelmintics->5.5.1 Drugs for threadworms Mefloquine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials MEFLOQUINE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Mefloquine MEPACRINE HYDROCHLORIDE 5.4 Antiprotozoal drugs->5.4.4 Antigiardial drugs Mepacrine Hydrochloride 5.4 Antiprotozoal drugs->5.4.4 Antigiardial drugs->mepacrine HYDROCHLORIDE Metrolyl 5.1 Antibacterial drugs-> Metronidazole and tinidazole->metronidazole METRONIDAZOLE 5.1 Antibacterial drugs-> Metronidazole and tinidazole Metronidazole 5.1 Antibacterial drugs-> Metronidazole and tinidazole->metronidazole METRONIDAZOLE 5.4 Antiprotozoal drugs->5.4.2 Amoebicides Neomycin 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->NEOMYCIN SULFATE
8 NEOMYCIN SULFATE 5.1 Antibacterial drugs->5.1.4 Aminoglycosides NEVIRAPINE 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors NITROFURANTOIN 5.1 Antibacterial drugs-> Urinary-tract infections Nitrofurantoin 5.1 Antibacterial drugs-> Urinary-tract infections->nitrofurantoin Norvir 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->ritonavir Noxafil 5.2 Antifungal drugs->5.2.1 Triazole antifungals->posaconazole OFLOXACIN 5.1 Antibacterial drugs-> Quinolones Ofloxacin 5.1 Antibacterial drugs-> Quinolones->OFLOXACIN OSELTAMIVIR 5.3 Antiviral drugs->5.3.4 Influenza OXYTETRACYCLINE 5.1 Antibacterial drugs->5.1.3 Tetracyclines Oxytetracycline 5.1 Antibacterial drugs->5.1.3 Tetracyclines->OXYTETRACYCLINE PALIVIZUMAB 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus Paludrine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil->PROGUANIL HYDROCHLORIDE Pentacarinat 5.4 Antiprotozoal drugs->5.4.8 Drugs for pneumocystis pneumonia->pentamidine ISETIONATE PENTAMIDINE ISETIONATE 5.4 Antiprotozoal drugs->5.4.8 Drugs for pneumocystis pneumonia PHENOXYMETHYLPENICILLIN 5.1 Antibacterial drugs->5.1.1 Penicillins-> Benzylpenicillin and phenoxymethylpenicillin Phenoxymethylpenicillin 5.1 Antibacterial drugs->5.1.1 Penicillins-> Benzylpenicillin and phenoxymethylpenicillin->phenoxymethylpenicillin PIPERACILLIN WITH TAZOBACTAM 5.1 Antibacterial drugs->5.1.1 Penicillins-> Antipseudomonal penicillins Piperacillin with tazobactam 5.1 Antibacterial drugs->5.1.1 Penicillins-> Antipseudomonal penicillins->piperacillin WITH TAZOBACTAM Prezista 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->darunavir Primaquine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials PRIMAQUINE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Primaquine Primaquine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Primaquine->PRIMAQUINE Proguanil 5.4 Antiprotozoal drugs->5.4.1 Antimalarials PROGUANIL HYDROCHLORIDE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil
9 PYRAZINAMIDE 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Pyrimethamine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials Quinine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials QUININE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Quinine Quinine Sulfate 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Quinine->QUININE RALTEGRAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals Retrovir 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->zidovudine Reyataz 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->atazanavir RIBAVIRIN 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus Rifadin 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->rifampicin RIFAMPICIN 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Rifampicin 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->rifampicin RIFAMPICIN WITH ISONIAZID 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Rifinah 150/ Antibacterial drugs->5.1.9 Antituberculosis drugs->rifampicin WITH ISONIAZID Rifinah 300/ Antibacterial drugs->5.1.9 Antituberculosis drugs->rifampicin WITH ISONIAZID Rimactane 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->rifampicin RITONAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors SAQUINAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors Sporanox 5.2 Antifungal drugs->5.2.1 Triazole antifungals->itraconazole STAVUDINE 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors STREPTOMYCIN 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Sustiva 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors->efavirenz Synagis 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus->palivizumab Tamiflu 5.3 Antiviral drugs->5.3.4 Influenza->OSELTAMIVIR Tarivid 5.1 Antibacterial drugs-> Quinolones->OFLOXACIN Tazocin 5.1 Antibacterial drugs->5.1.1 Penicillins-> Antipseudomonal penicillins->piperacillin WITH TAZOBACTAM TELAPREVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C
10 Telzir 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->fosamprenavir TENOFOVIR DISOPROXIL 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors TERBINAFINE 5.2 Antifungal drugs->5.2.5 Other antifungals TRIMETHOPRIM 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim Trimethoprim 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->trimethoprim Trizivir Truvada 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->abacavir->with lamivudine and zidovudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->tenofovir DISOPROXIL->With emtricitabine VALACICLOVIR 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection Valaciclovir 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection->valaciclovir Valcyte 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Cytomegalovirus infection->valganciclovir VALGANCICLOVIR 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Cytomegalovirus infection Valtrex 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection->valaciclovir Vfend 5.2 Antifungal drugs->5.2.1 Triazole antifungals->voriconazole Vibramycin-D 5.1 Antibacterial drugs->5.1.3 Tetracyclines->DOXYCYCLINE Videx 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->didanosine Viramune 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors->nevirapine Viread 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->tenofovir DISOPROXIL Voractiv 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->rifampicin->combined preparations VORICONAZOLE 5.2 Antifungal drugs->5.2.1 Triazole antifungals Wellvone 5.4 Antiprotozoal drugs->5.4.8 Drugs for pneumocystis pneumonia->atovaquone With abacavir 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->lamivudine With abacavir and lamivudine With abacavir and zidovudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->zidovudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->lamivudine With chloroquine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil->PROGUANIL HYDROCHLORIDE
11 With efavirenz and emtricitabine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->tenofovir DISOPROXIL With efavirenz and tenofovir 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->emtricitabine With emtricitabine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->tenofovir DISOPROXIL With emtricitabine and tenofovir 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors->efavirenz With flucloxacillin 5.1 Antibacterial drugs->5.1.1 Penicillins-> Broad-spectrum penicillins->ampicillin With lamivudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->abacavir With lamivudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->zidovudine With lamivudine and zidovudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->abacavir With lopinavir 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->ritonavir With proguanil hydrochloride 5.4 Antiprotozoal drugs->5.4.8 Drugs for pneumocystis pneumonia->atovaquone With tenofovir 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->emtricitabine With zidovudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->lamivudine ZANAMIVIR 5.3 Antiviral drugs->5.3.4 Influenza Zeffix 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->lamivudine Zerit 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->stavudine Ziagen 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->abacavir ZIDOVUDINE 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors Zidovudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->zidovudine Zovirax 5.3 Antiviral drugs->5.3.2 Herpesvirus infections-> Herpes simplex and varicella zoster infection->aciclovir AMIKACIN Restricted 5.1 Antibacterial drugs->5.1.4 Aminoglycosides Azactam Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Other beta-lactam antibiotics->aztreonam->parenteral AZITHROMYCIN Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides Azithromycin Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides->AZITHROMYCIN AZTREONAM Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Other beta-lactam antibiotics
12 Cancidas Restricted 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals->caspofungin CEFALEXIN Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Cefalexin Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFALEXIN CEFIXIME Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins CEFOTAXIME Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Cefotaxime Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFOTAXIME CEFTAZIDIME Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Ceftazidime Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFTAZIDIME CEFTRIAXONE Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Ceftriaxone Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFTRIAXONE CEFUROXIME Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Cefuroxime Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFUROXIME Ceporex Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFALEXIN CIPROFLOXACIN Restricted 5.1 Antibacterial drugs-> Quinolones Ciprofloxacin Restricted 5.1 Antibacterial drugs-> Quinolones->CIPROFLOXACIN Ciproxin Restricted 5.1 Antibacterial drugs-> Quinolones->CIPROFLOXACIN CO-TRIMOXAZOLE Restricted 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim Co-trimoxazole Restricted 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->co-trimoxazole DAPSONE Restricted 5.1 Antibacterial drugs-> Antileprotic drugs Dapsone Restricted 5.1 Antibacterial drugs-> Antileprotic drugs->dapsone Daptomycin Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials DAPTOMYCIN Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->daptomycin Dificlir Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->fidaxomicin->fidaxomicin Ecalta Restricted 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals->anidulafungin ERTAPENEM Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Carbapenems
13 Fasigyn Restricted 5.1 Antibacterial drugs-> Metronidazole and tinidazole->tinidazole Fidaxomicin Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials FIDAXOMICIN Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->fidaxomicin Fortum Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFTAZIDIME Fusidic acid Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials Glycopeptides Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials Hiprex Restricted 5.1 Antibacterial drugs-> Urinary-tract infections->methenamine HIPPURATE IMIPENEM WITH CILASTATIN Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Carbapenems Invanz Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Carbapenems->ERTAPENEM Kefadim Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFTAZIDIME Keflex Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFALEXIN LEVOFLOXACIN Restricted 5.1 Antibacterial drugs-> Quinolones Linezolid Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials LINEZOLID Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->linezolid LYMECYCLINE Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines Mecillinams Restricted 5.1 Antibacterial drugs->5.1.1 Penicillins Meronem Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Carbapenems->MEROPENEM MEROPENEM Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Carbapenems METHENAMINE HIPPURATE Restricted 5.1 Antibacterial drugs-> Urinary-tract infections MINOCYCLINE Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines Minocycline Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines->MINOCYCLINE MOXIFLOXACIN Restricted 5.1 Antibacterial drugs-> Quinolones Parenteral PIVMECILLINAM HYDROCHLORIDE Restricted Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Other beta-lactam antibiotics->aztreonam 5.1 Antibacterial drugs->5.1.1 Penicillins-> Mecillinams
14 POSACONAZOLE Restricted 5.2 Antifungal drugs->5.2.1 Triazole antifungals PYRIMETHAMINE Restricted 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Pyrimethamine Rifaximin Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials RIFAXIMIN Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->rifaximin Rocephin Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFTRIAXONE Selexid Restricted 5.1 Antibacterial drugs->5.1.1 Penicillins-> Mecillinams->PIVMECILLINAM HYDROCHLORIDE Septrin Restricted 5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->co-trimoxazole SODIUM FUSIDATE Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->fusidic acid Stribild Restricted 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->tenofovir DISOPROXIL->With cobicistat, elvitegravir, and emtricitabine Suprax Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFIXIME Targaxan Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->rifaximin->rifaximin Targocid Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->glycopeptides->teicoplanin Tavanic Restricted 5.1 Antibacterial drugs-> Quinolones->LEVOFLOXACIN TETRACYCLINE Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines Tetralysal 300 Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines->LYMECYCLINE Tigecycline Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines TIGECYCLINE Restricted 5.1 Antibacterial drugs->5.1.3 Tetracyclines->Tigecycline TINIDAZOLE Restricted 5.1 Antibacterial drugs-> Metronidazole and tinidazole TINIDAZOLE Restricted 5.4 Antiprotozoal drugs->5.4.2 Amoebicides TOBRAMYCIN Restricted 5.1 Antibacterial drugs->5.1.4 Aminoglycosides Vancocin Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->glycopeptides->vancomycin VANCOMYCIN Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->glycopeptides Vancomycin Restricted 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->glycopeptides->vancomycin Zinacef Restricted 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFUROXIME Zithromax Restricted 5.1 Antibacterial drugs->5.1.5 Macrolides->AZITHROMYCIN
15 Abelcet 5.2 Antifungal drugs->5.2.3 Polyene antifungals->amphotericin->lipid formulations Amantadine 5.3 Antiviral drugs->5.3.4 Influenza->AMANTADINE HYDROCHLORIDE AmBisome 5.2 Antifungal drugs->5.2.3 Polyene antifungals->amphotericin->lipid formulations AMINOSALICYLIC ACID 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Ancotil 5.2 Antifungal drugs->5.2.5 Other antifungals->flucytosine ARTEMETHER WITH LUMEFANTRINE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Artemether with lumefantrine Avelox 5.1 Antibacterial drugs-> Quinolones->MOXIFLOXACIN BEDAQUILINE 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Bramitob 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->TOBRAMYCIN->Inhalation Cayston 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Other beta-lactam antibiotics->aztreonam->inhalation CEFTOBIPROLE 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins CEFTOLOZANE WITH TAZOBACTAM 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Chloramphenicol 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->chloramphenicol->chloramphenicol Clarithromycin m/r preparations 5.1 Antibacterial drugs->5.1.5 Macrolides->CLARITHROMYCIN->Modified release COBICISTAT 5.3 Antiviral drugs->5.3.1 HIV infection->pharmacokinetic enhancers of antiretrovirals Colistimethate sodium 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->polymyxins->colistimethate SODIUM Colobreathe 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->polymyxins->colistimethate SODIUM Colomycin 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->polymyxins->colistimethate SODIUM Copegus 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus->ribavirin Cresemba 5.2 Antifungal drugs->5.2.1 Triazole antifungals->isavuconazole Cubicin 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->daptomycin->daptomycin DACLATASVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C Daklinza 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->DACLATASVIR Daraprim 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Pyrimethamine->PYRIMETHAMINE
16 DASABUVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C DELAMANID 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs Deltyba 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->delamanid Demeclocycline hydrochloride 5.1 Antibacterial drugs->5.1.3 Tetracyclines->DEMECLOCYCLINE HYDROCHLORIDE DOLUTEGRAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals Edurant 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors->rilpivirine ELBASVIR WITH GRAZOPREVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C ELVITEGRAVIR 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals Epclusa 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->SOFOSBUVIR WITH VELPATASVIR Eurartesim 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Piperaquine with artenimol->piperaquine PHOSPHATE WITH ARTENIMOL Eviplera 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->tenofovir DISOPROXIL->With emtricitabine and rilpivirine Evotaz 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->atazanavir->with cobicistat Exviera 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->DASABUVIR Fomicyt 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->fosfomycin->fosfomycin FOSFOMYCIN 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->fosfomycin Fosfomycin 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->fosfomycin->fosfomycin Fucidin 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->fusidic acid->sodium FUSIDATE Granupas 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->aminosalicylic ACID Griseofulvin 5.2 Antifungal drugs->5.2.5 Other antifungals->griseofulvin Harvoni 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->SOFOSBUVIR WITH LEDIPASVIR Imipenem with cilastatin 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Carbapenems->IMIPENEM WITH CILASTATIN Incivo 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->TELAPREVIR ISAVUCONAZOLE 5.2 Antifungal drugs->5.2.1 Triazole antifungals Kemicetine 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->chloramphenicol->chloramphenicol
17 Lamisil 5.2 Antifungal drugs->5.2.5 Other antifungals->terbinafine Lariam 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Mefloquine->MEFLOQUINE Levofloxacin 5.1 Antibacterial drugs-> Quinolones->LEVOFLOXACIN Lymecycline 5.1 Antibacterial drugs->5.1.3 Tetracyclines->LYMECYCLINE Malarivon 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Chloroquine->CHLOROQUINE Malarone 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil->PROGUANIL HYDROCHLORIDE WITH ATOVAQUONE Malarone Paediatric 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil->PROGUANIL HYDROCHLORIDE WITH ATOVAQUONE Mebendazole 5.5 Anthelmintics->5.5.1 Drugs for threadworms->mebendazole Meropenem 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Carbapenems->MEROPENEM Monuril 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->fosfomycin->fosfomycin Moxifloxacin 5.1 Antibacterial drugs-> Quinolones->MOXIFLOXACIN Mycamine 5.2 Antifungal drugs->5.2.4 Echinocandin antifungals->micafungin Nevirapine 5.3 Antiviral drugs->5.3.1 HIV infection->non-nucleoside reverse transcriptase inhibitors->nevirapine Nivaquine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Chloroquine->CHLOROQUINE Olysio 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->SIMEPREVIR OMBITASVIR WITH PARITAPREVIR AND RITONAVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C Oseltamivir 5.3 Antiviral drugs->5.3.4 Influenza->OSELTAMIVIR Paludrine/Avloclor 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Chloroquine->CHLOROQUINE->With proguanil Pentostam 5.4 Antiprotozoal drugs->5.4.5 Leishmaniacides->SODIUM STIBOGLUCONATE PIPERAQUINE PHOSPHATE WITH ARTENIMOL PROGUANIL HYDROCHLORIDE WITH ATOVAQUONE 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Piperaquine with artenimol 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Proguanil Promixin 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->polymyxins->colistimethate SODIUM Pyrimethamine with sulfadoxine 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Pyrimethamine->PYRIMETHAMINE WITH SULFADOXINE
18 Quinine Dihydrochloride 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Quinine->QUININE Rebetol 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus->ribavirin Relenza 5.3 Antiviral drugs->5.3.4 Influenza->ZANAMIVIR Rezolsta 5.3 Antiviral drugs->5.3.1 HIV infection->protease inhibitors->darunavir->with cobicistat Riamet 5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Artemether with lumefantrine->artemether WITH LUMEFANTRINE Rifater 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->rifampicin->combined preparations SIMEPREVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C Sirturo 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->bedaquiline Sivextro 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->tedizolid->tedizolid SOFOSBUVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C SOFOSBUVIR WITH LEDIPASVIR SOFOSBUVIR WITH VELPATASVIR 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C Sovaldi 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->SOFOSBUVIR TEDIZOLID 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->tedizolid TEICOPLANIN 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->glycopeptides TELAVANCIN 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->glycopeptides Terbinafine 5.2 Antifungal drugs->5.2.5 Other antifungals->terbinafine Tivicay 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals->dolutegravir Tobi 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->TOBRAMYCIN->Inhalation Tobramycin 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->TOBRAMYCIN->Parenteral Triumeq 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->abacavir->with lamivudine and dolutegravir Tybost 5.3 Antiviral drugs->5.3.1 HIV infection->pharmacokinetic enhancers of antiretrovirals->cobicistat Tygacil 5.1 Antibacterial drugs->5.1.3 Tetracyclines->Tigecycline->TIGECYCLINE Vantobra 5.1 Antibacterial drugs->5.1.4 Aminoglycosides->TOBRAMYCIN->Inhalation Vermox 5.5 Anthelmintics->5.5.1 Drugs for threadworms->mebendazole
19 Vibativ 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->glycopeptides->telavancin Victrelis 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->BOCEPREVIR Viekirax 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->OMBITASVIR WITH PARITAPREVIR AND RITONAVIR Virazole 5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus->ribavirin Vitekta 5.3 Antiviral drugs->5.3.1 HIV infection->other antiretrovirals->elvitegravir Zedbac 5.1 Antibacterial drugs->5.1.5 Macrolides->AZITHROMYCIN Zepatier 5.3 Antiviral drugs->5.3.3 Viral hepatitis-> Chronic hepatitis C->ELBASVIR WITH GRAZOPREVIR Zerbaxa Zevtera 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFTOLOZANE WITH TAZOBACTAM 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFTOBIPROLE Zidovudine and lamivudine 5.3 Antiviral drugs->5.3.1 HIV infection->nucleoside reverse transcriptase inhibitors->zidovudine->with lamivudine Zinamide 5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs->pyrazinamide Zinforo 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins->CEFTAROLINE FOSAMIL Zyvox 5.1 Antibacterial drugs->5.1.7 Some other antibacterials->linezolid->linezolid
Report generated from BNF provided by FormularyComplete ( Accessed TA Number. Title Formulary Status Section
Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACICLOVIR Aciclovir 5.3 Antiviral drugs->5.3.2
More information5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and
5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs
More informationChapter 5 ~ Infections
Chapter 5 ~ Infections: Special Section 1 of 6 Chapter 5 ~ Infections Please refer to The Hillingdon Hospitals NHS Trust Antibiotic Guidelines, Policy number 233, and Surgical Prophylaxis Policy, Policy
More informationNHS Fife Antibiotic Guidance for the Treatment of Community Managed Infections
1 5. Infections Also see Primary Care and Hospital Antibiotic Guidance NHS Fife Antibiotic Guidance for the Treatment of Community Managed Infections Management of Serious Infections in Paediatrics. Guidance
More informationALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS
ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS - 2014 Alabama s ADAP formulary offers a minimum of one medication from each HIV antiretroviral class approved by the U.S. Food and Drug Administration (FDA).
More informationChapter 5 Infections
Chapter 5 page number 1 Chapter 5 Infections First line drugs Drugs recommended in both primary and secondary care. Second line drugs Alternatives (often in specific conditions) in both primary and secondary
More informationHIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily
HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ alafenamide Emtricitabine/
More informationREIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO
REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO Ont. Drug Distr. Ontario Drug Benefit/Trillium: Other Formulary (F/A) Limited Use (Section 16) Antiretrovirals AZT 100 mg capsules NRTIs (single): Abacavir,
More informationInventory of paediatric therapeutic needs
12 December 2012 EMA/PDCO/287222/2012 Human Medicines Development and Evaluation Infectious diseases Agreed by PDCO November 2012 Adopted by PDCO for release for consultation 7 December 2012 Start of public
More informationFORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary
At a Glance: VA ADAP Formulary Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) Non Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Multi Class Combination Agents Protease Inhibitors
More informationHIV Drugs and the HIV Lifecycle
HIV Drugs and the HIV Lifecycle Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject All HIV drugs work by interrupting different steps in HIV's
More informationAntiretroviral Dosing in Renal Impairment
Protease Inhibitors (PIs) Atazanavir Reyataz hard capsules 300 mg once daily taken with ritonavir 100 mg once daily No dosage adjustment is needed for atazanavir in renal impairment Atazanavir use in haemodialysis
More information1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017
To support national and global efforts to increase access to and the affordability of care and treatment of HIV/AIDS, hepatitis B and C, tuberculosis, malaria, neglected tropical diseases, influenza, diarrhoea
More informationDaclatasvir (Daklinza ) Drug Interactions with HIV Medications
Daclatasvir/Sofosbuvir (Daklinza /Sovaldi TM ) Drug Interactions A Quick Guide for Clinicians April 2017 John J Faragon, PharmD, BCPS, AAHIVP Mechanism of Action and Route of Metabolism for Daclatasvir
More informationTHE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work
THE HIV LIFE CYCLE Understanding How Antiretroviral Medications Work DEFINITIONS Host: The animal or cell that another organism lives in. In HIV human CD4 T-cells are the host for HIV. Nucleus: The core
More informationHospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing
Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing Infections therapeutic group PTAC and Subcommittee of PTAC minutes are
More informationBoth adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members)
Infectious Diseases Society of America Emerging Infections Network Report for Query: Antimicrobial Drug Shortages 2016 Overall response rate: 701/1,597 (44%) physicians responded from 3/22/16 to 4/13/16.
More informationWOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION
WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION A1. PARTICIPANT ID: ENTER NUMBER HERE - - - ONLY IF ID LABEL IS NOT AVAILABLE A2. VISIT #: A3. VERSION DATE: 1 0 /
More informationMedication Guide. October Contents. Preferred Medication List
October 08 Medication Guide Please consider talking to your doctor about prescribing one of the formulary medications that are indicated as covered under your plan; which may help reduce your out-of-pocket
More informationWOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM
WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM ID LABEL HERE ---> VERSION DATE 10/01/07 - - - VISIT #: FORM COMPLETED BY: A1. DATE OF BLOOD DRAW: / / M D Y A2. Do you take
More informationDrug Treatment Program Update
Drug Treatment Program Update As of March 211 Drug Treatment Program Update A key component of the Centre s mandate is to monitor the impact of HIV/AIDS on British Columbia. The Centre provides essential
More informationRecommended Comparator Products: Medicines for HIV/AIDS and Related Diseases
Medicines for HIV/AIDS and Related Diseases Comparator products should be purchased from a well-regulated market with a stringent regulatory authority. 1 Invited medicinal products Abacavir, 60 mg, 300
More informationThis letter authorises the extended use of the following guidance until 1st December 2018:
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS NHS Grampian Date 29 1h May 2018 Our Ref FApenicillin/hype/MGPG/May 18 Enquiries to Frances Adamson Extension 56689 Direct Line 01224
More informationB. Incorrect! Peginterferon α-2a is used for the treatment of chronic hepatitis B and may be preferable to interferon- α.
Pharmacology - Problem Drill 24: Antibiotics, Antifungal and Antiviral Drugs Question No. 1 of 10 1. reduces the replication of influenza A and B viruses by inhibiting viral neuraminidase. Question #01
More informationgram neg.(semisynthetic) Bacteria Drugs that inhibit cell wall synthesis Drug Action Organisms Comments Spectrum of Action Mycobacterium
Mickey Dufilho s Drugs and Bugs Revised 10/10/15 Bacteria Drugs that Inhibit Cell Wall Synthesis Drug Action Spectrum of Action Comments Spectrum of Action Bacitracin Beta-Lactam antibiotics Penicillin
More informationANTIRETROVIRAL TREATMENTS (Part 1of
CCR5 CO-RECEPTOR ANTAGONISTS maraviroc (MVC) Selzentry 25mg, 75mg, FUSION INHIBITORS 20mg/mL ANTIRETROVIRAL TREATMENTS (Part 1of 5) oral soln enfuvirtide (ENF, T-20) Fuzeon 90mg/mL pwd for SC inj after
More informationAntiretrovial Crushable/Liquid Formulation Chart
Antiretrovial Crushable/Liquid Formulation Chart Eliza Dollard, PharmD; Nafeesa Chin-Beckford, PharmD; Laura Aragon, PharmD Last Updated: 04/2016 Agent How Supplied Crushable Status **Products listed in
More informationDrug Typical Dose CrCl (ml/min) Dose adjustment for renal insufficiency Acyclovir PO (HSV) 400 mg TID >10 <10 or HD PD
Antimicrobial Dosing in Renal Insufficiency (Adults) ASP Handbook * In patients on hemodialysis (), give antimicrobial immediately after dialysis on dialysis days. = Intermittent hemodialysis = Peritoneal
More informationFluconazole dimenhydrinate, diphenhydramine. Raltegravir or dolutegravir with antacids
Supportive therapy Summary of interactions Table 1. Summary of potential interactions between antiretroviral agents and supportive therapy Interactions with enzyme inhibitors (protease inhibitors and elvitegravir/cobicistat)
More informationMedication Guide. July Contents. Click to search for a drug name in this document
July 06 Medication Guide Click to search for a drug name in this document Contents Introduction... I Medication list... II Changes to the formulary... II Your Share of Expenses... III Pharmacy Benefits...
More informationAppropriate Use & Safety Edits
Appropriate Use & Safety Edits Envolve Pharmacy Solutions provides a variety of safety edits to promote the use of the right medication, in the right patient, at the right time. These edits are routinely
More informationtreatment passport 1
treatment passport 1 Why keep a treatment history? Keeping a short record of your treatment history can help in many ways. It can help you understand your health and treatment. It can help if your doctor
More informationRecommended comparator products: Medicines for HIV/AIDS and related diseases
Recommended comparator products: Medicines for HIV/AIDS and related diseases Comparator products should be purchased from a well regulated market with stringent regulatory authority 1. Invited medicinal
More informationDrug Classification and Pharmacologic Actions
Drug Classification and Pharmacologic Actions Learning Outcomes For major classes of drugs: Identify common drug names for each classification Describe actions- therapeutic uses Describe most common or
More informationHealth Insurance Marketplace 6 Tier Drug List
January 09 Health Insurance Marketplace 6 Tier Drug List Please consider talking to your doctor about prescribing preferred medications, which may help reduce your out-of-pocket costs. This list may help
More informationHIV medications HIV medication and schedule plan
Living with HIV (human immunodeficiency virus) It may be scary to find out that you re HIV-positive or have AIDS. Coping with this news may be difficult. Although HIV is a serious infection, people with
More informationPrescription Drug Guide
2013 Prescription Drug Guide Humana Formulary List of covered drugs Humana Complete (PDP) Region 6 States of Pennsylvania and West Virginia PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS
More informationHuman Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications
Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications Carrie Allen PharmD, CGP, BCPS, BCPP, CCHP Overview - Part 2: HIV
More informationPHARMACOKINETICS OF ANTIRETROVIRAL AND ANTI-HCV AGENTS
8. PHARMACOKINETICS OF ANTIRETROVIRAL AND ANTI-HCV AGENTS David Burger José Moltó Table 8.1a: INFLUENCE OF FOOD ON ABSORPTION (AREA UNDER THE CURVE) OF ANTIRETROVIRAL AGENTS NUCLEOSIDE ANALOGUES NtRTI
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationCURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs
page 1 CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs 2011 The following categories are included in this work programme: 1. Medicines
More informationTORONTO GENERAL HOSPITAL HIV AMBULATORY CARE ROTATION
TGH - ambulatory rotation page 1 of 5 TORONTO GENERAL HOSPITAL HIV AMBULATORY CARE ROTATION SITE: Immunodeficiency Clinic, Toronto General Hospital, University Health Network Location: 13 th floor, Norman
More informationDrug Class Review Monograph GPI Class 12 Antivirals
Drug Class Review Monograph GPI Class 12 Antivirals Review Time Frame: 02/2016 04/2017 Previous Class Review: 05/2016 Background: Antiviral agents are used to treat infections caused by viruses, including,
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationMedication Guide. January Contents
January 06 Medication Guide Contents Introduction... I Medication list... II Changes to the formulary... II Your Share of Expenses... III Pharmacy Benefits... III Medications that are not covered... III
More informationNothing to disclose.
Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital HIV UPDATE FOR THE PRIMARY CARE PROVIDER Nothing to disclose. 1 Outline Epidemiology Screening / testing for HIV
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationFORMULARY. (List of Covered Drugs) Molina Dual Options MyCare Ohio (Medicare-Medicaid Plan)
FORMULARY (List of Covered Drugs) 2015 Molina Dual Options MyCare Ohio (Medicare-Medicaid Plan) Version 14 UPDATED: 11/2015 Member Services (855) 665-4623, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m.
More informationBHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search
BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search Search 1 :When to Initiate ART Covers Questions 1-5 including to prevent transmission Component Description Review area Objectives
More information2019 PHP PRIMARY CARE INCENTIVE
Primary Care Physicians (PCP) of Physicians Health Network (PHN) may be eligible for an incentive payment in accordance with this PHP PCP Incentive (hereinafter referred to as the PCP Incentive ). As described
More information104 MMWR December 17, 2004
104 MMWR December 17, 2004 TABLE 8. Substantial pharmacokinetic drug-drug interactions for drugs used in the treatment of opportunistic Drugs Interacting with Mechanism/effects Recommendations Acyclovir
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More information2016 Prescription Drug Guide
2016 Prescription Drug Guide Humana Medicare Employer Plan Formulary List of covered drugs Humana Group Medicare Plus 1 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
Arkansas Blue Cross and Blue Shield Metallic Formulary 2018 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies to
More informationPage 1 of 5 ENLGLISH / ESPAÑOL / PORTUGUÉS / FRANÇAIS Share 3 Drug Chart for HIV Treatment CURRENT EDITION ABOUT SENSE BACK ISSUES MSMGF HOME CONTACT US There are a number of antiretroviral (ARV) medications
More informationBlue MedicareRx SM Premier (PDP) 2018 Formulary (List of Covered Drugs)
Blue MedicareRx SM Premier (PDP) 2018 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN This formulary was updated on 07/01/2018. For
More informationCOMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL
Generic Name COMPREHENSIVE ANTIRETROVIRAL TABLE: NUCLOESIDE/TIDE REVERSE TRANSCRIPTASE INHIBITORS (N(t)RTIs) Abacavir ABC (Ziagen) Didanosine ddi (Videx EC) Emtricitabine FTC (Emtriva) Lamivudine 3TC (Epivir)
More informationNorthwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care
Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care www.nwaetc.org The Northwest AIDS Education and Training Center (NW AETC), located at the University
More informationAIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010
AIDS Drug Assistance Program ADAP-Miami NEEDS ASSESSMENT July 16, 2010 ADAP Clients - Gender ADAP Clients by Gender FY 09/10 April 2010 to June 2010 26% 0% Males Females 26% 0% Males Females Transgender
More informationMONTEFIORE MEDICAL CENTER
DEPARTMENT OF PHARMACY MONTEFIORE MEDICAL CENTER SUBJECT: MANUAL CODE: Restricted Drugs Policy, Antibiotic Restriction PH-R-5 DATE ISSUED: August, 1976 DATE REVISED: September 2000, October 2003, September
More information5 - Infections. In alphabetical order Product Manufacturer. NHS Lothian decision. Date of NHS Lothian decision. Condition being treated
Recommendations from the Lothian Formulary Committee (FC) following Scottish Medicines Consortium (SMC) advice, NICE MTA advice, (FAF3) unlicensed and off-label medicines and (FAF2) medicines not considered
More informationHIV Management Update 2015
9/30/15 HIV Management Update 2015 Larry Pineda, PharmD, PhC, BCPS Visiting Assistant Professor Pharmacy Practice and Administrative Science ljpineda@salud.unm.edu Pharmacist Learning Objectives Describe
More informationHIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options
STRATEGIES FOR THIRD LINE HIV THERAPY issues to consider when faced with few drug options A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS MAY 2008 Most people living
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 37 1. NAME OF THE MEDICINAL PRODUCT Tablets* 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg efavirenz, 200 mg emtricitabine
More informationInvitation to Manufacturers 16 August 2017
Invitation to Manufacturers 16 August 2017 Manufacturers of Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial medicines Are Invited to Submit An Expression of Interest
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
FUZEON (enfuvirtide) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
October, 08 Arkansas Blue Cross and Blue Shield Metallic Formulary 08 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies
More informationArkansas Blue Cross and Blue Shield Metallic Formulary List of Covered Drugs
December, 08 Arkansas Blue Cross and Blue Shield Metallic Formulary 08 List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use network pharmacies
More informationAntiretroviral Nucleoside reverse transcriptase inhibitor (NRTI)
1 2004-2005 Respiratory Review 2 Abacavir Nucleoside reverse transcriptase inhibitor (NRTI) 3 Acebutolol β 1 adrenergic antagonist Class II antiarrhythmic Antianginal 4 Albuterol β 2 adrenergic agonist
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More informationGeneric Name Brand Name Restrictions or Notes 1a. ANTIRETROVIRALS-ENTRY INHIBITORS (1) 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(2)
1a. ANTIRETROVIRALS-ENTRY INHIBITORS (1) maraviroc Selzentry 1b. ANTIRETROVIRALS-INTEGRASE INHIBITOR(2) raltegravir Isentress, Isentress HD dolutegravir Tivicay 1c. ANTIRETROVIRALS-NUCLEOSIDE& NUCLEOTIDE
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 36 1. NAME OF THE MEDICINAL PRODUCT mg/300 mg Tablets* 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg efavirenz, 200 mg
More informationMIC Test Strip for antimicrobial susceptibility testing
for antimicrobial susceptibility testing Liofilchem Liofilchem Quantitative assay for determining the Minimum Inhibitory Concentration (M.I.C.) is a quantitative assay for determining the Minimum Inhibitory
More information2018 Comprehensive List of Covered Drugs
Healthcare Marketplace Comprehensive Exchange Drug List: CY2018 2018 Comprehensive List of Covered Drugs PLEASE READ: THIS DOCUMENT HAS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Members must use
More informationUpdated Guidelines for Managing HIV/HCV Co-Infection
Updated Guidelines for Managing HIV/HCV Co-Infection John J Faragon, PharmD, BCPS, AAHIV-P Regional Pharmacy Director, NY/NJ AIDS Education and Training Center Pharmacist, HIV Medicine, Albany Medical
More informationCOMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING**, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL
COMPREHENSIVE ANTIRETROVIRAL TABLE: NUCLOESIDE/TIDE REVERSE TRANSCRIPTASE INHIBITORS (N(t)RTIs) Abacavir ABC (Ziagen) Didanosine ddi (Videx EC) Emtricitabine FTC (Emtriva) Lamivudine 3TC (Epivir) Stavudine
More informationDivision of Public Health Services Office of the Assistant Director Public Health Preparedness Services
Division of Public Health Services Office of the Assistant Director Public Health Preparedness Services 150 North 18 th Avenue, #110 JANICE K. BREWER, GOVERNOR Phoenix, AZ 85007-3233 WILL HUMBLE, DIRECTOR
More informationWorld AIDS Day Year-by-Year Milestones in HIV/AIDS. healthlibrary
World AIDS Day 2014 Year-by-Year Milestones in HIV/AIDS (Adapted from The POZ Timeline: Milestones in the HIV/AIDS Pandemic with additions compiled by Eric Brus, Director of HIV Health Promotion, AIDS
More informationJULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet
JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationHIV Infection & AIDS in Low- and Middle-Income Countries
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 25: HIV Infection & AIDS in Low- and Middle-Income Countries Author P. Van de Perre, MD, PhD Chapter Editor Michelle Doll, MD, MPH Topic Outline Key Issues
More informationINDEX. indications...11 initiation of metabolic and morphologic complications
Index 287 INDEX 3TC...245 246 3TC/FTC...66 67 Abacavir...68, 218 Abacavir + lamivudine...219 220 Abacavir + lamivudine + zidovudine...220 ABC...218 Absolute neutrophil counts (ANC)...136, 137 Acidosis,
More informationSection H: Treatments
TIME THIS SECTION BEGINS RECORDED HERE TSST04H Section H: Treatments H1. Have you ever taken AZT, a protease inhibitor, or any other drugs such as those listed on this card to treat your HIV infection
More information1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016
To support national and global efforts to increase access to and the affordability of HIV/AIDS-related care and treatment together with UNICEF, UNAIDS and UNITAID, invite applicants for selected pharmaceutical
More informationADULT ANTIMICROBIAL DOSING TOOL (NB Provincial Health Authorities Anti-Infective Stewardship Committee, September 2017)
(NB Provincial Health Authorities Anti-Infective Stewardship Committee, September 2017) Introduction The dosing recommendations presented here are for adults with moderate-to-severe infections and are
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 36 1. NAME OF THE MEDICINAL PRODUCT mg/300 mg Tablets* 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg efavirenz, 200 mg
More informationcontinuing education for pharmacists
continuing education for pharmacists HIV/AIDS: Overview and Resources for Pharmacists Mona T. Thompson, R.Ph., PharmD Volume XXXIII, No. 9 Dr. Mona T. Thompson has no relevant financial relationships to
More informationAIDS DRUG ASSISTANCE PROGRAM (ADAP) FORMULARY - CLIENT VERSION
AIDS DRUG ASSISTANCE PROGRAM (ADAP) FORMULARY - CLIENT VERSION June 9, 2017 (Alternate strengths and dose forms - with exclusion of injectable forms unless the medication is only available in such route
More information2019 Formulary List of Covered Drugs. Passport Advantage (HMO SNP) ADVANTAGE (HMO SNP)
ADVANTAGE (HMO SNP) Passport Advantage (HMO SNP) 2019 Formulary List of Covered Drugs PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN HPMS Approved Formulary File
More informationMonographs on ARV and hepatitis medicines in The International Pharmacopoeia
Monographs on ARV and hepatitis medicines in The International Pharmacopoeia Technologies, Standards and Norms 1 The International Pharmacopoeia contains analytical methods and specifications for active
More informationValueScript Rx Medication Guide
ValueScript Rx Medication Guide February Please consider talking to your doctor about prescribing one of the formulary medications that are indicated as covered under your plan; which may help reduce your
More informationHepatitis C Medications Prior Authorization Criteria
Hepatitis C Medications Authorization Criteria Epclusa (/velpatasvir), Harvoni (ledipasvir/), Sovaldi (), Daklinza (daclatasvir), Zepatier (elbasvir/grazoprevir), Olysio (simeprevir), Viekira Pak (ombitasvir/paritaprevir/ritonavir;
More informationCOMPOUNDED STERILE PREPARATIONS RECONSTITUTION, DILUTION AND STABILITY CHART (ADULT)
FH Pharmacy Department ACYCLOVIR 3 (PPC) AMIKACIN 2,3 AMPHOTERICIN B 1,4 (Fungizone ) AMPHOTERICIN B 1.3 Lipid Complex (Abelcet ) AMPHOTERICIN B 1.3 Liposomal (Ambisome ) AMPICILLIN 1,3 (Teva, PPC) ARGATROBAN
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS Page 1 of 34 1. NAME OF THE MEDICINAL PRODUCT AVIRODAY-EM * 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 600 mg efavirenz, 200 mg emtricitabine
More information0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920
0.14 UNAIDS 0.053% 2 250 60 10% 94 73 20 73-94/6 8,920 12 43 Public Health Service Task Force Recommendations 5-10% for Use of Antiretroviral Drugs in 10-20% Pregnant HIV-1-Infected Women for Maternal
More information